From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.

Tao Y, Zhou J, Wang Y, Mao Y, Lei X, Chen E

Open source

DOI
10.3389/fphar.2026.1871275
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1871275,
  title = {From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.},
  author = {Tao Y and Zhou J and Wang Y and Mao Y and Lei X and Chen E},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1871275},
  url = {https://doi.org/10.3389/fphar.2026.1871275}
}

RIS

TY  - JOUR
TI  - From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.
AU  - Tao Y
AU  - Zhou J
AU  - Wang Y
AU  - Mao Y
AU  - Lei X
AU  - Chen E
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1871275
UR  - https://doi.org/10.3389/fphar.2026.1871275
ER  - 

APA

Y, T., J, Z., Y, W., Y, M., X, L., & E, C. (2026). From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1871275

Source records